# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- Court Filing
- SEC Filing
HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Timber Pharmaceuticals (AMEX:TMBR) from Buy to Neutral.
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow t...